Tag: Schedule III

SAFE Banking is back in Congress, but operators should not plan around passage just yet. Here is what the bill covers, why the Senate remains the challenge, and what Schedule III does not solve.

Medical cannabis businesses have until June 26 to preserve expedited DEA registration review. Cannabis Business Advisors founder Sara Gullickson explains why the filing should prompt a hard look at license records, ownership disclosures, product flows, SOPs, security controls, and traceability before federal oversight becomes more consequential.

Splash Beverage Group (NYSE: SBEV) appoints Sunburn Cannabis CEO Brady Cobb to lead its strategic pivot from alcohol to the high-growth cannabinoid and regulated wellness sectors.

While the federal reclassification of cannabis to Schedule III is being hailed as a historic milestone, for dispensary owners, the “victory” comes with a complex set of operational strings attached. From the selective application of 280E tax relief to the slow-moving evolution of the banking sector, the transition is more about precision than celebration. This guide breaks down why the “medical lane” is the new front line of profitability, how to audit your revenue streams for upcoming tax shifts, and why compliance documentation is now more critical than ever.

The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.

PORTLAND, Ore. – Analysts at Whitney Economics (WE) estimates cannabis businesses paid $2.24 billion in excess cannabis-related federal taxes in 2025 due to the...

Schedule III could reduce the tax drag that has warped cannabis operating models for years, but it won’t be a universal win. The real advantage will go to operators who treat post-280E relief as a catalyst: moving faster, tightening inventory and receivables, stress-testing pricing and production, and getting books “deal-ready” before M&A velocity spikes. In the gap between improved economics and slower-moving capital markets, preparedness becomes market power.

WASHINGTON – Cannabis rescheduling is up in the air again after the administrative law judge assigned to hear arguments for and against the proposal...

WASHINGTON – The National Cannabis Roundtable (NCR) and US Cannabis Council (USCC) agreed to combine the two organizations that represent leading multistate and single-state cannabis...

Donald Trump’s reelection has left the cannabis industry facing familiar questions about its future under a federal landscape that repeatedly has dangled reform without...